Searchable abstracts of presentations at key conferences in endocrinology

ea0065p142 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Living with and beyond childhood cancer – endocrine impact up to 40 years on

Surandran Sanggeeta , Idama Ella , Windsor Rachael , Davies Melanie , Grandage Victoria , Simpson Helen

Objective: To review impact of childhood cancer treatment on endocrine, gonadal and thyroid function.Methods: Retrospective review of electronic records of 79 females, 90 males over 6 months of clinic visits from a Late Effects of childhood cancer clinic. Age at diagnosis: 8.5 years (range 5 months–9 years); time from treatment 23.5 years (range 10–40). Diagnoses: ALL, AML, Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, sarcomas, Wilms, ...

ea0066p9 | Bone | BSPED2019

Evidence for association of PTEN-harmatoma-tumor syndrome with osteosarcoma

Kwong Ruth Ming Wai , El-Khairi Ranna , Windsor Rachael , Gevers Evelien

Introduction: PTEN-harmatoma-tumor syndrome is an umbrella term that describes a group of genetic disorders linked to germline mutations of PTEN (Phosphatase and tensin homolog), a tumor suppressor gene that inhibits the PI3/Akt signalling pathway thereby inhibiting proliferation, cell survival and angiogenesis. PTEN-harmatoma-tumor syndrome encompasses Cowden‘s Syndrome, Bannayan–Riley–Ruvalcaba syndrome, and autism spectrum disorder (ASD) associated with macro...